Sera Prognostics
Salt Lake City
About Sera Prognostics
Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera provides pivotal information during pregnancy to physicians, designed to help improve the health of their patients, and to reduce the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the prediction of preterm birth risk and other complications of pregnancy. Sera’s PreTRM® Test reports to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $295.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2025)
- Ticker: nasdaq:SERA
- Website: seraprognostics.com
- Phone: 801-990-0520
Industries & Categories
Biotechnology, Health Care, Hospital, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sera-prognostics-37725 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.